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Abstract 
Background: More than half of the world’s population is infected with Helicobacter pylori (H. pylori), the primary 
cause of chronic gastritis. Chronic gastritis is associated with peptic ulcer and in advanced stages with an increased 
risk of developing gastric adenocarcinoma. In many developing countries access to upper gastrointestinal (UGI) 
endoscopy services is limited. As a result, many UGI diseases are treated empirically.
Objective: To determine the prevalence of H. pylori in patients presenting with dyspepsia, and the mean time from 
onset of symptoms to performing an endoscopy examination.
Methods: A cross sectional descriptive study conducted from 5th January to 30th April 2014. Adult patients with 
dyspepsia who were referred for UGI endoscopy were recruited consecutively. Questionnaires were used to collect 
data which were analyzed using STATA software. IRB approval was obtained.
Results: In total, 111 participants’ data were analyzed. The F:M ratio was 1:1.4, mean age 43 years (SD = 16). The 
prevalence of H. pylori gastritis was 36%. The minimum time to endoscopy was 3 weeks, maximum 1,248 weeks and 
the mean time 57 weeks.
Conclusion: The burden of H. pylori infection in patients with dyspepsia was high. Patients had prior empirical antibi-
otic therapy. Access to endoscopic services is limited.
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Background
Endoscopy is essential in the classification of the patient’s 
condition as organic or functional dyspepsia [1–5]. Heli-
cobacter pylori is a gram negative microaerophilic bac-
terium that causes inflammation of the stomach, first 
isolated by Barry Marshall and Robin Warren in 1982. It is 
a highly prevalent infection in developing countries with 
poor socio-economic status and an etiologic agent of the 
majority of upper gastrointestinal (UGI) diseases associ-
ated with significant morbidity [6]. The regimens recom-
mended by National institute of Clinical Excellence for 
H. pylori eradication are omeprazole, amoxicillin, and 
clarithromycin (OAC) for 10 days; bismuth subsalicylate, 
metronidazole, and tetracycline (BMT) for 14  days; and 
lansoprazole, amoxicillin, and clarithromycin (LAC) for 
10–14  days of treatment. More than half of the world’s 
population is infected with H. pylori, the primary cause of 
chronic gastritis. Chronic gastritis is associated with pep-
tic ulcer and in advanced stages with an increased risk of 
developing gastric adenocarcinoma [7]. In many develop-
ing countries facilities for UGI endoscopy are rare. As a 
result, the diagnosis of UGI diseases is carried out solely 
on clinical parameters in most cases. Incorrect/delayed 
diagnoses, and subsequent ineffective management, 
results in increased morbidity, economic loss to the client, 
and even death especially in patients with malignancy [4]. 
The objective of this study therefore was to determine the 
prevalence of H. pylori associated gastritis among patients 
with dyspepsia and to determine the mean time from 
onset of symptoms to endoscopic procedure.
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Methods
This was a cross-sectional descriptive study of patients 
with dyspepsia that presented to a tertiary hospital for 
UGI Endoscopy from 5th January to 30th April 2014.
Mulago National Referral Hospital (MNRH) doubles 
as Makerere University Teaching Hospital and therefore 
receives patients from all over the Country as well as the 
neighboring countries for expert management. MNRH is 
located in Kampala the capital of Uganda. Patients with 
dyspepsia present to the gastroenterology clinic. Fur-
ther management depends on the decision made by the 
attending doctor. Some patients are sent for endoscopy, 
others are started on empirical treatment.
All patients who presented with dyspepsia during 
the study period and met the inclusion criteria were 
recruited consecutively upon signing a written informed 
consent.
The inclusion criterion was patients presenting with 
undiagnosed dyspeptic symptoms and age 18  years and 
above.
Dyspepsia symptoms included One or more of the fol-
lowing symptoms; postprandial fullness (termed post-
prandial distress syndrome); early satiation (meaning 
inability to finish a normal sized meal or postprandial 
fullness) and Epigastric pain or burning epigastric pain 
(termed epigastric pain syndrome).
Exclusion criteria Patients with alarm symptoms 
(weight loss, haematemesis, persistent vomiting) were 
excluded from this study.
Patient preparation involved 6 h of fasting. In conscious 
patients, a topical anesthetic xylocaine 5% was sprayed 
into the oropharynx to numb the gag reflex. Sedation 
with intravenous midazolam 0.1  mg/kg was used at the 
discretion of the attendant.
Endoscopic evaluation of patients was carried out 
using a fibre optic gastro-duodenoscope Olympus and 
following standard procedures. Instrument steriliza-
tion was done using a routine technique of cleaning the 
instrument with cetrimide, 70% alcohol, glutaraldehyde 
(Cidex®) and later running equipment in distilled water 
for up to 30 min in between endoscopic sessions. Patients 
were placed in the left lateral decubitus with pulse oxi-
metry monitoring of their vital sign by the anaesthetist. 
All anatomic regions of the esophagus, stomach, first 
and second parts of the duodenum whenever possible 
were examined and endoscopic impressions noted. Pinch 
mucosal biopsies for histopathological diagnoses and H. 
pylori detection were obtained from the antrum, stomach 
and suspicious areas for all cases.
The diagnoses conformed to standards as reflected in 
the atlas of gastrointestinal endoscopy [8].
The histopathological diagnosis of H. pylori infection 
in biopsy specimen was done using the Modified Giemsa 
stain which is easy to interpret, inexpensive, and takes 
about 5 min to perform, and rarely requires repeat stains. 
It has a sensitivity of 98% and specificity of 90% [9].
Study variables
The social demographic factors were: age, sex, occupa-
tion, marital status, home address, and level of education. 
Others included: alcohol consumption, cigarette smok-
ing, and use of non steroidal anti-inflammatory drugs, 
proton pump inhibitors, and antibiotics. Also included 
were clinical variables: postprandial fullness, early satia-
tion, epigastric pain.
The dependent variables were microscopic diagnoses 
(histologically confirmed H. pylori associated gastritis), 
changes of inflammation, dysplasia or metaplasia, cancer 
of the upper gastrointestinal tract and macroscopic diag-
nosis (endoscopic diagnoses) including but not limited to 
duodenitis, peptic ulcer disease (PUD), gastroesophageal 
reflux disease (GERD) using savory miller grading.
Data analysis
Data were analyzed using STATA version13. The results 
were presented as mean ± standard deviation for quan-
titative variables and number (percentages) for qualita-
tive variables. Categorical variables were compared with 
Pearson’s Chi square. Significant P value was taken as 
<0.05 at 95% CI.
Gastritis was further classified into its various forms. 
The prevalence of H. pylori associated gastritis was calcu-
lated as total number of patients with H. pylori associated 
gastritis divided by the total number of study subjects 
and expressed as a percentage.
The topography/patterns of gastritis was documented 
as pan-gastritis or antral predominant, etc. and expressed 
as percentages out of the total cases of gastritis.
Ethical considerations
Ethical approval was obtained from the Research and 
Ethics Committee of the College of Health Sciences of 
Makerere University. Written informed consent was 
obtained from all the participants.
Results
We recruited 111 patients (see Figure 1) with a F:M ratio 
of 1:1.4. The mean age was 43  years (SD 16) and the 
median age was 40. All the participants were residing in 
Kampala an urban area. All the participants had formal 
education with the majority having attained a tertiary 
level of education 52/111 (47%).
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Risks factors
There were nine smokers, smoking an average of two 
stick a day, over 52–502  week duration. However one 
participant smoked four sticks a day.
The majority 97/111 (87%) of study participants did not 
consume spirits. Of the 14 who took spirits, 8 (57%) took 
about a liter a week, and 2 (14%) consumed about 3 L a 
week.
The majority of the study participants that consumed 
beer took about 2  L a week, except one male who 
reported consumption of about 8  L on average every 
week.
Two study participants reported wine consumption, 
about 0.5 L a week.
Nine participants, all above 55 years of age had been on 
NSAIDS for over 3 weeks.
Of the 34 participants who presented with post pran-
dial fullness, 25 (73%) had it for 6 months or longer. Of 
the 25 participants who presented with early satiety, 20 
(80%) had it for 6 months or longer. Of the 100 patients 
who presented with epigastric pain, 86 (86%) had it for 
6  months or longer. Seven cases had heart burn as well 
as dyspepsia, 10/111 (9%) had a combination of all three 
symptoms of dyspepsia and 12/111 (11%) had a combina-
tion of two symptoms.
The overall prevalence of H. pylori associated gastritis 
was 40/111 (36%) at 95% CI (27–45).
Out of the 40 patients with H. pylori at histopathology, 
21 (52.5%) were in a tertiary institution, or had attained 
a tertiary level of education, 31/40 (77.5%) had been tak-
ing PPIs at the time of endoscopy. The highest prevalence 
22/40 (55%) was in the age category of less than or equal 
to 40 years and 17/40 (42.5%) had not been on antibiotics 
at the time of endoscopy. Out of the 76 patients who had 
moderate epigastric pain, 24 (32%) had H. pylori at histol-
ogy. The majority [35/40 (87.5%)] cases of H. pylori were 
seen in biopsy specimen from the stomach (Table 1).
The association of H. pylori and the above variables was 
not statistically significant [the p values were greater than 
0.05 at 95%.
The minimum duration of symptoms before endoscopy 
was 3  weeks, and the maximum 1,248  weeks. The aver-
age time to endoscopy was 126  weeks, and the median 
57 weeks.
The commonest diagnosis was gastritis 82/111 (74%). 
The commonest pattern of gastritis was moderate gas-
tritis of the antrum and body 40/82 (49%) followed by 
moderate pan gastritis 24/82 (29%). Only 7/111 (6%) par-
ticipants had severe disease (gastric ulcer, duodenal ulcer 
and tumors) see Figure 2.
The tumors were involving the gastro-jejunal junction 
and fundus and the other was in the cardia.
3 patients had normal findings at both endoscopy and 
histopathology.
There were 7/111 (6%) cases of hiatus hernia. Three of 
these were large and associated with reflux oesophagitis 
savory miller grade 1 at endoscopy.
The commonest histopathological diagnosis was 
chronic non active gastritis.
A total of 40/111 (36%) participants had H. pylori at 
histopathology.
The two cases of duodenal ulcer had H. pylori infection 
at histopathology.
One participant who had moderate gastritis of the 
antrum and body at endoscopy had adenocarcinoma 
in  situ. The other case of adenocarcinoma had a mass 
involving the fundus and gastro esophageal junction.
The tumor that was involving the cardia turned out to 
be a moderately differentiated squamous cell carcinoma.
Discussion
We set out to establish the prevalence of H. pylori 
gastritis among patients presenting for endoscopic 
examination.
We found that over 36% had H. pylori gastritis and 
that it took 57  weeks on average for the participants to 
access endoscopic services from the time of develop-
ing symptoms. H. pylori prevalence goes from less than 
15% in some populations to virtually 100% depending 
on socio economic status and country development. In 
High income Countries exposure tends to occur later in 
life, which results in lower percentages in infected adults, 
an average of 20–30% of adults are infected by age of 50. 
In this study those ≤40 years was 55%, twice as much as 
stated for some High Income Countries. It is anticipated 
that the prevalence of H. pylori infection will decline as 
sanitary conditions improve and it is also a reflection of 
wide spread use of antibiotics [10].
Helicobacter pylori infection has been reported by sev-
eral studies to be high in developing countries, and asso-
ciated with low levels of education, low social economic 
status, and poor sanitation [4, 11].
Figure 1 Recruitment flow chart.
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Table 1  H. pylori’s distribution by age groups, level of education, antibiotic use, severity of epigastric pain, early satiety, 
post prandial fullness, and endoscopic macroscopic findings
Variable H. pylorus absence  
number (%)
H. pylorus presence  
number (%)
OR (95% CI) p value
Age group in years
 ≤40 34 (48) 22 (55)
 >40 37 (52) 18 (45) 0.75 (0.35–1.64) 0.472
Level of education
 Primary 11 (15) 5 (13) Reference
 Secondary 29 (41) 14 (35) 1.06 (0.31–3.65) 0.924
 Tertiary 31 (44) 21 (53) 1.49 (0.45–4.92) 0.512
Antibiotic use
 None 42 (59) 17 (43) Reference
 ≤2 weeks 25 (35) 22 (55) 2.17 (0.97–4.86) 0.058
 >2 weeks 4 (6) 1 (3) 0.62 (0.06–5.93) 0.676
Severity of pain
 Mild 6 (9) 3 (8) Reference
 Moderate 52 (81) 24 (65) 0.92 (0.21–4.01) 0.915
 Severe 6 (9) 10 (27) 3.33 (0.60–18.54) 0.169
Macro findings
 Stomach 56 (82) 35 (88)
 Others 12 (18) 5 (13) 0.67 (0.22–2.05) 0.480
Early satiety
 Never 54 (76) 33 (82.50)
 Experienced 17 (24) 7 (18) 0.67 (0.25–1.80) 0.430
Postprandial fullness
 Never 46 (65) 31 (78)
 Experienced 25 (35) 9 (23) 0.53 (0.22–1.30) 0.166
Figure 2 Distribution of macroscopic lesions by region.
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NSAID use and H. pylori infection have a significant 
impact on endoscopic findings while presence of H. 
pylori, smoking and alcohol consumption are all associ-
ated with increased risk of developing chronic gastritis 
[11]. In this study the consumption of cigarettes was low 
however the consumption of alcohol was moderate.
The overall prevalence of H. pylori associated gastritis 
may be an under estimate since the majority of the par-
ticipants had been on prior empirical treatment with 
antibiotics. However, this value is similar to one found 
by Wabinga et al. [12] in his retrospective study in 2002. 
In contrast, studies in 2012 in neighboring Kenya [13] 
reported a 52% prevalence of H. pylori in adults [14].
In Nigeria, a 41% prevalence was reported in Lagos 
state in 2008 [11]. Notably, all the above studies were car-
ried out in an urban settings where there is congestion, 
perhaps sub optimal sanitary conditions but easy access 
to antibiotics compared to rural settings.
In the East Cape province of South Africa in 2008, 
66.1% H. pylori prevalence was reported [15]. The East 
Cape Province is one of the poorest provinces of South 
Africa.
The majority of patients (close to 80%) had been on 
prior empirical treatment as opposed to the test and treat 
approach practiced in some countries with a low preva-
lence of H. pylori.
However close to half of the H. pylori infected adults 
had not been on antibiotics at the time of endoscopy. 
Also one patient had H. pylori despite taking eradications 
antibiotics for over 4 weeks prior to endoscopic examina-
tion. Perhaps a case of resistance to the regimen used.
The odds of H. pylori positivity were reduced in 
those who had taken antibiotics for more than 2 weeks. 
OR  =  0.62 (0.06–5.93). A possible explanation is that 
eradication is likely achieved after 2 weeks of therapy.
The time from onset of symptoms to the endoscopic 
procedure was not normally distributed. The minimum 
duration of symptoms before endoscopy was 3  weeks, 
and the maximum 1,248  weeks. The average time to 
endoscopy was 125.6  weeks, and the median 57  weeks. 
This is the first study that looked at the time duration 
from onset of dyspeptic symptoms to the endoscopic 
procedure in Uganda. This reflects on the limitation to 
accessing endoscopic services. The findings suggest that 
the average time from onset of symptoms to the defini-
tive diagnosis by endoscopy is about a year. This might be 
a long time, bearing in mind that H. pylori is a potent risk 
factor for malignancy [12]. In this study, a 37  years old 
presented with dyspepsia (without alarm symptoms), was 
found with moderate H. pylori gastritis of the antrum and 
body and adenocarcinoma in  situ. Clinicians have to be 
aware that dyspepsia in the young could be cancer [16]. 
In a systematic review of 4,018 patients the use of alarm 
symptoms to select dyspeptic patients for endoscopy 
caused patients with early curable cancers to be over-
looked [17].
The commonest macroscopic finding was gastritis 
similar to Kagimu et  al. [12], Wabinga et  al. in Uganda 
[12], Sang Thomas et  al. [13] and Kimang et  al. [14] In 
Kenya, Sang Thomas et al. found 4% normal findings at 
endoscopy and Kimangi et  al. found that 100% of the 
study participants with dyspepsia had abnormal findings 
at endoscopy. In the Eastern Cape province S.A, 33.6% 
of the patients had functional dyspepsia [15]. Similarly, 
Abioudun et  al. in Nigeria found that gastritis was the 
commonest finding, but also found a high incidence of 
H. pylori in the endoscopically normal study participants 
[18]. In contrast, in Italy, a case control study by Zagari 
et al. of 1,033 study participants found that ¾ were nor-
mal endoscopically. In his study, 93.4% of PUD patients 
had H. pylori at histology [19]. In Korea, Jung et al. and 
colleagues found that 40% of the study participants were 
normal endoscopically in 2012.
Despite the relatively high prevalence of H. pylori 
infection, only a few study participants had severe dis-
ease (PUD and malignancy). Two [2] participants had 
H. pylori associated duodenal ulcers, and three patients 
had malignancy. Sang Thomas et al. in Kenya found that 
30% of his study participants had PUD with H. pylori and 
73.6% of these had H. pylori [13] of the 82 patients with 
Gastritis 7 (8.5%] had severe gastritis at endoscopy and 
their histology confirmed H. pylori presence.
This study found that seven participants (6.3%) had hia-
tus hernia at endoscopy presented with dyspepsia plus 
heart burn. This is in contrast to the majority of the stud-
ies mentioned above that all had less than 2% of these 
cases and reflux oesophagitis.
Study limitations
One major limitation of this study is that it was con-
ducted in a hospital setting and this may not be a true 
representation of the prevalence of H. pylori among dys-
peptics in the general population. A community study is 
therefore desirable. Study involving asymptomatic con-
trols was desirable but because endoscopy is expensive 
and invasive, it was not possible to get study participants.
The study participants did not have an abdominal ultra 
sound done to exclude other causes of undiagnosed dys-
pepsia, pancreatitis and hepatobiliary disease, especially 
for those that had normal endoscopic findings.
There could have been recall bias as participants were 
required to remember when their symptoms started.
Conclusion
The burden of H. pylori infection among dyspeptic 
patients was high. There is limited access to endoscopic 
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services and widespread prior antibiotic empirical treat-
ment. Gastritis is the commonest finding at endoscopy in 
patients presenting with dyspepsia.
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